Louis Gries
Analyst · Citigroup. Please go ahead
Thank you. Hi, everybody. Thanks for joining the call. I'm in Europe with Matt Marsh. We'll walk through the results in a normal way. If you go to slide 5, you'll see the agenda. We actually have added an item, Fermacell Update, but you'll soon find it is not much of an update because we haven’t closed, so we can't talk about it, but I, now we'll go to the Operating Review and I'll hand it over to Matt for financial review and then we'll come back to questions and answers. So going to slide 7, we've got our Fermacell slide which is something we covered in November after we entered into the purchase agreement. We did put a bridge loan facility in place in December and everything is striking down plan and we expect to close the acquisition late fourth quarter. Slide number 9, filtered down the – this business overview is going to be an easy result to talk to because everything in the businesses did go pretty much as expected and pretty much how we've been indicating we thought would perform after fiscal year '18. The EBIT margin in the quarter was higher than I think most people expected including us and that's just a reflection of most things in the business in the last quarter kind of went to the positive variance side. That's the operations, the pricing was good. The volume was good and I'll comment on that in North America and Asia-Pac continue to perform very well. So you put it all again, we've got a little bit more on the EBIT margin line than we were expecting, but it is consistent with the story we started the year with and that's going to be a backwards year meaning we're going to get better as we went through the year which is unusual seasonal impact in the U.S. but that's how it has played out and we can't expect to continue with the current momentum. You can see the cash flow is down a bit. We talked to you. In the U.S. we went to a new program for winter distribution of inventory close to the market so that program has been running well and seems to be working for us the way we wanted it to work, but does result in higher inventory this quarter being pulled down in the first quarter of next year. North American specifically you can see prices pretty much what we've been doing throughout the year, a good price gap of 5%. Sales volume, the comp is 2% which is better than the second quarter obviously. We got there by getting to market rate on exteriors a quarter quicker than we thought we were going to. So our gains then we'd be 2% or 3% up on last year this quarter as things played out the way we thought they would, we actually come in more at the market index rate of above 5 on exteriors. Pouring it down at 2% was negative interiors comp, the negative interiors comp not necessarily happened half but it was driven by the product line exits we did early last year and early this year late last year and then we're just traction in some regions in retail, we lost traction in gypsum regions and we need to regain that. But so that's how we got there on volume. Obviously the EBIT came in strong. Like I said everything kind of just went just a bit better than expected and that added up to EBIT margin coming in very high for the third quarter. Third quarter is normally our lowest margin quarter. Your page 11, delivered unit cost. We give you that graph now because obviously we got it off track with our unit cost and you can see we've kind of gotten selves back on track. The low indications for Q1 and Q2 of '17, I think we have communicated that, we didn’t think those were sustainable. We didn’t think. We thought they were lower than they should be. We weren’t spending at the, you know ideal level. We were under spending in our plants. So we kind of took care of that and that's a big part that we pulled the unit cost up and we've now come back down just to back down. We're comfortable with spending levels in the plant. We've done a lot at catch-up where we felt we had to do. You can see us Q3 '18 is about the same as our Q3 '17. That's despite the fact that input costs are up and freight costs are up, so we were offsetting and pretty much offset that improved performance over same quarter last year. Go to slide 12, you know I had commented that it was going to be backwards year and it is turning into a backwards year, meaning you know either Q1, Q2 is normal year investing that margin market and then you take the dip in three and then four and you see had a bit of a bounce back. So we came in very weak in the first quarter starting to get some of our financial traction back or bottom line back in the second quarter and like I said it came in a little bit higher in the third quarter although we were expecting that to improve in the third quarter. I'm not going to [indiscernible] that here. If we go to slide 13, I commented early that prices went south all year, not much going on there. We took an increase this time last year. It was an effective increase. We had a mixed advantage going forwards this year reportedly due to the product line exits I referred to earlier, but also you know when interior is tracking behind exteriors, interiors is lower price product line. So that gives you a little mix advantage when it comes to price and then our tactical pricing has been well managed. We've gotten better when that tactical pricing efficiency over the last two or three years and that's been showing up pretty good for us. Top line growth, obviously you guys know that story we talked about getting our traction back in the market, so we got top line growth from price and a little bit of volume this quarter and we expect that to improve as we move into next year. We're not really changing, you know when you get to G&A you're going to find we're not really changing our story of how we think this plays out. We think the quarter was pretty much as expected. So it doesn't lead us to a more bullish view at this point. So I think our PDG [ph] we talked about 3 to may be 5 next year. We still feel the same way about that. We feel our EBIT margin will be good. We have the capacity lined up to service the market. We have our programs to drive PDG fully funded. So everything is kind of as we've been talking right through the year and this is just this quarter to me is more of a confirmation that we're on the track that we felt we are on rather than something that would you know a quarter that would lead us to change our expectations. Slide 14, International Fiber Cement it's just had a really solid year and it continues to perform well month to month, quarter to quarter. Go to slide 15 and you'll see the only little negative is our New Zealand plant hasn’t performed as well as it should and we've had a little bit of an EBIT drop there, but other than that, you know, Asia-Pac has been a really strong performer for us and we expect that to continue. You've seen down in Europe, in the Europe it says lower volume in certain regions and then says little better EBIT result due to lower SG&A basically we're more selective on our market participation than we were over the last couple of years we've kind of got out of some product markets that we didn’t think had as much value for us. Obviously with the purchase of Fermacell we're going to reset our whole approach to fiber cement in Europe. So it's not really, I wouldn't want it to be read as any kind of pull back, it's just kind of a fixing up the base business in Europe which is still pretty small until we get into a relaunch in a more high growth organic strategy post Fermacell acquisition, after it closes. Okay, I'll hand it over to Matt Marsh.